🇺🇸 FDA
Patent

US 10160733

Methods for producing viloxazine salts and novel polymorphs thereof

granted A61PA61P13/00A61P25/00

Quick answer

US patent 10160733 (Methods for producing viloxazine salts and novel polymorphs thereof) held by Supernus Pharmaceuticals, Inc. expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P13/00, A61P25/00, A61P25/20, A61P25/24